MarginsXMarginsX
Home › Markets › Health Care › AXGN

Axogen Inc. (AXGN)

AXGN trades on Nasdaq in Health Care, Biotechnology: Electromedical & Electrotherapeutic Apparatus. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$55.38
-0.98% on the day
Market cap
$3.3B
Mid cap
Revenue · 2025
$225.2M
+20.2% on 2024
Net income · 2025
-$15.7M
-7.0% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/805928/000080592826000031/0000805928-26-000031-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerAXGN on Nasdaq
SectorHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000805928
SEC industry codeElectromedical & Electrotherapeutic Apparatus
Incorporated inMN

Financials · 2025

LineValue
Revenue$225.2M
Net income-$15.7M
Operating income-$7.8M
Net margin-7.0%
Operating margin-3.5%
Revenue growth+20.2%
Cash$35.5M
Total assets$221.7M
P/E (computed)Net income was not positive
P/S (computed)14.7×

Warning signs

Cash runway
Cash-flow positive
$328.9M cash at September 30, 2026
Share count, 1 year
+29.5%
2025-10-27 to 2026-10-26 · +38.8% over 3 years
Going-concern doubt
No
10-Q filed October 28, 2026
Insider net buying, 12 months
-$19.9M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-10-28
Cash and burn$328.9M cash; operating cash flow $7.1M a quarter.Report 2026-09-30
Shares outstanding59,730,715 (2026-10-26); 46,122,289 a year earlier; 43,043,606 three years earlier.Cover page 2026-10-26
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 3 424B5 takedowns, 3 at the marketLatest 2026-09-10
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorDeloitte & Touche LLP, Tampa, Florida, United StatesPCAOB Form AP 2026-03-11
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $19.9M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$75.8M$2.3M$16.5M$328.9M$0$266.9M10-Q 2026-10-28
Q2 2026
2026-06-30
$69.7M-$1.5M$7.2M$94.6M$0$251.2M10-Q 2026-07-29
Q1 2026
2026-03-31
$61.5M-$19.6M$1.6M$82.7M$0$238.1M10-Q 2026-04-28
Q4 2025
2025-12-31
$59.9M-$13.2M$3.0M$35.5M$48.4M$225.2M10-K 2026-02-24
Q3 2025
2025-09-30
$60.1M$708K$3.2M$23.9M$48.2M$214.7M10-Q 2026-10-28
Q2 2025
2025-06-30
$56.7M$579K$7.7M$20.0M$47.9M$203.3M10-Q 2026-07-29
Q1 2025
2025-03-31
$48.6M-$3.8M-$13.2M$18.1M$47.7M$194.5M10-Q 2026-04-28
Q4 2024
2024-12-31
$49.4M$450K$8.7M$27.6M$47.5M$187.3M10-K 2026-02-24

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-09-10
Latest annual report
FORM 10-K
10-K2026-02-24
Latest quarterly / interim
FORM 10-Q
10-Q2026-10-28
Latest current report
FORM 8-K
8-K2026-11-09
Latest proxy
AXGN DEFINITIVE PROXY STATEMENT
DEF 14A2026-04-29

Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+11.8%
1 month+54.6%
3 months+16.4%
Year to date+70.9%
1 year+132.7%
From 52-week high-4.6%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Electromedical & Electrotherapeutic Apparatus

TickerCompanyPriceDayMarket cap
TMDXTransMedics Group Inc.$92.21+0.91%$3.2B
LIVNLivaNova PLC$92.44+1.23%$5.1B
CNMDCONMED Corporation$49.35-2.45%$1.5B
CBLLCeriBell Inc.$26.42+1.07%$1.0B
INMDInMode Ltd.$13.15-0.90%$755.9M
CVCapsoVision Inc.$6.47+7.30%$346.9M
ELMDElectromed Inc.$23.10-5.02%$188.8M
FOCLEDAP TMS S.A.$3.17-2.39%$149.7M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier